Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason P Appleton

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Frontiers in Stroke|January 16, 2026
Cerebral edema in intracerebral hemorrhage: pathogenesis, natural history, and potential treatments from translation to clinical trialsKailash Krishnan, Paula Bermell Campos, Thanh N Nguyen, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|November 5, 2016
Baseline characteristics of the 3096 patients recruited into the 'Triple Antiplatelets for Reducing Dependency after Ischemic Stroke' trialPhilip Mw Bath, Jason P Appleton, Maia Beridze, et al.
Stroke and Vascular Neurology|May 21, 2019
It is safe to use transdermal glyceryl trinitrate to lower blood pressure in patients with acute ischaemic stroke with carotid stenosisJason P Appleton, Lisa J Woodhouse, Andrew Belcher, et al.
Lancet (London, England)|December 25, 2017
Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trialPhilip M Bath, Lisa J Woodhouse, Jason P Appleton, et al.
Health Technology Assessment (Winchester, England)|September 5, 2018
Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCTPhilip M Bath, Lisa J Woodhouse, Jason P Appleton, et al.
Stroke (Hoboken, N.J.)|January 26, 2026
Antiplatelet Resistance: A Review of Concepts, Mechanisms, and Implications for Management in Acute Ischemic Stroke and Transient Ischemic AttackKailash Krishnan, Thanh N Nguyen, Jason P Appleton, et al.
Journal of Neurointerventional Surgery|January 22, 2024
Safety and efficacy of adjunctive intra-arterial antithrombotic therapy during endovascular thrombectomy for acute ischemic stroke: a systematic review and meta-analysisOmar Marei, Anna Podlasek, Emma Soo, et al.
European Journal of Neurology|October 11, 2024
Pre-hospital transdermal glyceryl trinitrate for transient ischaemic attack: Data from the RIGHT-2 trialJason P Appleton, Mark Dixon, Lisa J Woodhouse, et al.
Stroke|December 1, 2021
Brief Consent Methods Enable Rapid Enrollment in Acute Stroke Trial: Results From the TICH-2 Randomized Controlled TrialZhe Kang Law, Jason P Appleton, Polly Scutt, et al.
Lancet (London, England)|May 21, 2018
Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trialNikola Sprigg, Katie Flaherty, Jason P Appleton, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Frontiers in Stroke|January 16, 2026
Cerebral edema in intracerebral hemorrhage: pathogenesis, natural history, and potential treatments from translation to clinical trialsKailash Krishnan, Paula Bermell Campos, Thanh N Nguyen, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|November 5, 2016
Baseline characteristics of the 3096 patients recruited into the 'Triple Antiplatelets for Reducing Dependency after Ischemic Stroke' trialPhilip Mw Bath, Jason P Appleton, Maia Beridze, et al.
Stroke and Vascular Neurology|May 21, 2019
It is safe to use transdermal glyceryl trinitrate to lower blood pressure in patients with acute ischaemic stroke with carotid stenosisJason P Appleton, Lisa J Woodhouse, Andrew Belcher, et al.
Lancet (London, England)|December 25, 2017
Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trialPhilip M Bath, Lisa J Woodhouse, Jason P Appleton, et al.
Health Technology Assessment (Winchester, England)|September 5, 2018
Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCTPhilip M Bath, Lisa J Woodhouse, Jason P Appleton, et al.
Stroke (Hoboken, N.J.)|January 26, 2026
Antiplatelet Resistance: A Review of Concepts, Mechanisms, and Implications for Management in Acute Ischemic Stroke and Transient Ischemic AttackKailash Krishnan, Thanh N Nguyen, Jason P Appleton, et al.
Journal of Neurointerventional Surgery|January 22, 2024
Safety and efficacy of adjunctive intra-arterial antithrombotic therapy during endovascular thrombectomy for acute ischemic stroke: a systematic review and meta-analysisOmar Marei, Anna Podlasek, Emma Soo, et al.
European Journal of Neurology|October 11, 2024
Pre-hospital transdermal glyceryl trinitrate for transient ischaemic attack: Data from the RIGHT-2 trialJason P Appleton, Mark Dixon, Lisa J Woodhouse, et al.
Stroke|December 1, 2021
Brief Consent Methods Enable Rapid Enrollment in Acute Stroke Trial: Results From the TICH-2 Randomized Controlled TrialZhe Kang Law, Jason P Appleton, Polly Scutt, et al.
Lancet (London, England)|May 21, 2018
Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trialNikola Sprigg, Katie Flaherty, Jason P Appleton, et al.
Pageof 6